Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Presentations

Presentations

The information set forth in the presentations posted on this page was factually accurate on the date it was issued. While these presentations remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, listeners to the presentations should not rely upon the information as current or accurate after their issuance dates.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)